Pharmacovigilace

Pharmacovigilance (PV) is concerned with monitoring the safety of all medications, starting from the early stages of development (including early research phases) throughout their entire life cycle, and continuing through to the commercialization stage. PV is responsible for the detection, assessment, understanding, and prevention of adverse effects that may arise from the use of medications.

Any drug, even those that have undergone a long development, research, or commercialization process and meet strict quality standards, has the potential to cause adverse events.

PV is a shared responsibility between the prescribing doctor, the pharmaceutical industry, health authorities, and patients. All PV activities promote the rational and safe use of medications for the benefit of public health.

Definition of an adverse event:
Any undesirable occurrence that happens to a patient while receiving a medication. An adverse event can, therefore, be any unfavorable and unintended sign or symptom that is temporarily associated with the use of a medicinal product, whether it is related to the product or not.

Therefore, if you have any questions about the safety of our products, we invite you to contact us. Reporting any adverse events, even those already known, can help identify issues related to drug safety.